throbber
Spivey Richard </O=CARTER-
`W ALLACE/OU=CRANMAIL/CN=RECIPIENTS/CN=EXCHANGE/CN=RSPIVEY>
`Monday, February 06, 2006 1:38:53 PM
`D'Addio Alex <ADAddio@medpointepharma.com>;Fuge Dennis
`<dfuge@medpointepharma.com>
`RE: Pfeiffer Bi Dose Nasal Spray System
`
`Sender:
`
`Sent:
`Recipient:
`
`Subject:
`
`Dennis,
`
`Could you mention this to Paul (or I can)? He is of the impression this is a dual chamber device. Please advise.
`
`Thanks,
`
`Rich
`
`-----Original Message----(cid:173)
`From: D'Addio Alex
`Sent: Saturday, February 04, 2006 3:36 PM
`To: Spivey Richard; Fuge Dennis
`Subject: RE: Pfeiffer Bi Dose Nasal Spray System
`
`Rich,
`
`You are correct. The Valois Bidose is a single-use device intended to deliver two sprays - one for each nostril - of a single
`formulation. It is a specialty device developed for use in applications such as mucosal vaccinations.
`
`Dennis,
`I am available after the Valois meeting to discuss development of a potential combo product.
`
`Alex
`
`-----Original Message----(cid:173)
`From: Spivey Richard
`Sent: Friday, February 03, 2006 8:35AM
`To: Fuge Dennis
`Cc: D'Addio Alex
`Subject: RE: Pfeiffer Bi Dose Nasal Spray System
`
`Good.
`
`Thanks,
`
`Rich
`
`-----Original Message----(cid:173)
`From: Fuge Dennis
`Sent: Fri Feb 03 08:12:48 2006
`To : Spivey Richard
`Cc : D'Addio Alex
`Subject:
`RE: Pfeiffer Bi Dose Nasal Spray System
`
`Rich,
`Valois are coming in on Monday to talk to us about the Bi Dose.
`Dennis
`
`From: Spivey Richard
`Sent: Thursday, February 02, 2006 10:41 PM
`
`HIGHLY CONFIDENTIAL
`-SUBJECT TO STIPULATED PROTECTIVE ORDER
`
`PLAINTIFFS'
`TRIAL EXHIBIT
`PTX0150
`
`MEDA_APTX03470974
`
`PTX0150-00001
`
`1
`
`CIP2121
`Argentum Pharmaceuticals LLC v. Cipla Ltd.
`IPR2017-00807
`
`

`

`To: Fuge Dennis
`Cc: D'Addio Alex
`Subject: RE: Pfeiffer Bi Dose Nasal Spray System
`
`You should discuss with Alex. Everyone is fully c01runitted at this point. We had always wanted to wait until after the proff of
`concept results (April) before spending much resource on this. It may be possible to do some rudimentary testing, but this should be
`discussed with Alex.
`
`Also, as we discussed, I have seen nothing that would indicate that the bi-dose is anything other than two doses, not a dual chamber.
`Can't we quickly find that out?
`
`Rich
`
`From: Fuge Dennis
`Sent: Monday, January 30, 2006 11:58 AM
`To: Spivey Richard
`Subject: RE: Pfeiffer Bi Dose Nasal Spray System
`
`Rich,
`As discussed there are likely to be a number of easier formulation options for the steroid compo product than going the dual
`device/chamber route. Can we tum Gulloose to do work on whether one of the existing steroid suspensions or solutions would accept
`the addition of Azelastine and be stable? I am not looking at a full development effort, just something small to confirm conceptually
`whether we are going to face major formulation issues or whether an existing formulation could be the starting point.
`
`In the meantime, I will explore device options with Valois.
`Best regards,
`Dennis
`
`From: Edick Paul
`Sent: Saturday, January 28, 2006 10:57 AM
`To : Fuge Dennis
`Cc: Fislunan Corey; Spivey Richard; Coniglio Tony
`Subject: RE: Pfeiffer Bi Dose Nasal Spray System
`
`Dennis,
`
`We should put this on the front burner and pursue as exclusive for use in Rhinitis applications ASAP.
`
`Paul
`
`From: Fuge Dennis
`Sent: Friday, January 27, 2006 10:54 AM
`To: sarah.malka@valois.com
`Cc: Spivey Richard; Coniglio Tony; Edick Paul; Fishman Corey
`Subject: Pfeiffer Bi Dose Nasal Spray System
`
`Sarah,
`At our meeting on February 6th could you give your brief perspective on the Pfeiffer's Bi Dose Nasal System and the types of
`products this device is used for, just so that we can assess whether this could be something worth exploring in the future?
`Could you also explain to us how the coordination of activities in the AptarGroup are actually working. Are there separate sales
`representatives? Would a supply agreement cover the total AptarGroup or just the Valois division?
`
`Thanks.
`Best regards,
`Dennis
`
`HIGHLY CONFIDENTIAL
`-SUBJECT TO STIPULATED PROTECTIVE ORDER
`
`MEDA_APTX03470975
`
`PTX0150-00002
`
`2
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket